| Insider-Aktien | 478.606.383 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
null Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in TKMR / getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Insider | Gemeldete Aktien |
Gemeldeter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Max |
Preis bei Max |
Max Gewinn ($) |
Max Rendite (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-24 | HENRIQUES RICHARD C JR | 1.000 | 6,9500 | 1.000 | 6,9500 | 6.950 | 24 | 7.56 | 610 | 8,78 |
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in TKMR / . Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | 2026-02-02 | 4 | Androski Lindsay | ABUS | Common Shares | D | 28.000 | 28.000 | ||||||
| 2026-02-02 | 2026-02-02 | 4 | Nguyen Tuan | ABUS | Common Shares | D | 73.500 | 73.500 | ||||||
| 2025-03-06 | 3 | Gline Matthew By Roivant Sciences Ltd. | ABUS | Common Shares | I | 38.847.462 | ||||||||
| 2025-02-19 | 2025-02-14 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 90.100 | 249.824 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 177.000 | 1.658.003 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 54.300 | 140.544 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Sims Karen | ABUS | Common Shares | D | 49.300 | 155.494 | ||||||
| 2025-02-05 | 2025-02-04 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 3,2830 | -11.333 | -37 | 86.244 | ||||
| 2025-02-05 | 2025-02-04 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 3,2830 | -23.790 | -78 | 1.481.003 | ||||
| 2025-02-05 | 2025-02-04 | 4 | Sims Karen | ABUS | Common Shares | D | 3,2830 | -19.348 | -64 | 106.194 | ||||
| 2025-02-05 | 2025-02-04 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 3,2830 | -22.183 | -73 | 159.724 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 3,6895 | -8.846 | -33 | 46.069 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 0,5600 | 54.915 | 31 | 54.915 | ||||
| 2024-02-05 | 2024-02-02 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 2,3125 | -9.593 | -22 | 181.907 | ||||
| 2024-02-05 | 2024-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 112.500 | 191.500 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sims Karen | ABUS | Common Shares | D | 2,3125 | -4.358 | -10 | 125.542 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sims Karen | ABUS | Common Shares | D | 101.000 | 129.900 | ||||||
| 2024-02-05 | 2024-02-01 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 95.100 | 95.100 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,3125 | -10.164 | -24 | 1.504.793 | ||||
| 2024-02-05 | 2024-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 123.800 | 1.514.957 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 2,3125 | -9.982 | -23 | 1.485.121 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 109.500 | 1.495.103 | ||||||
| 2023-07-12 | 3 | Sims Karen | ABUS | Common Shares | D | 28.900 | ||||||||
| 2023-02-03 | 2023-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 82.200 | 1.385.603 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 83.700 | 1.391.157 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Collier William H. | ABUS | Common Shares | D | 216.500 | 216.500 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 79.000 | 79.000 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Howard Elizabeth | ABUS | Common Shares | D | 69.700 | 86.024 | ||||||
| 2022-05-26 | 2022-05-25 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Meyers James R | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | BURGESS DANIEL D | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Torti Frank | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-01-20 | 2022-01-20 | 4 | Picchio Gaston | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 256.500 | 721 | 256.500 | |||
| 2022-01-20 | 2022-01-20 | 4 | Sofia Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285.000 | 801 | 285.000 | |||
| 2022-01-20 | 2022-01-20 | 4 | Howard Elizabeth | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 237.500 | 667 | 237.500 | |||
| 2022-01-20 | 2022-01-20 | 4 | HASTINGS DAVID C | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285.000 | 801 | 285.000 | |||
| 2022-01-20 | 2022-01-20 | 4 | McElhaugh Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 325.850 | 916 | 325.850 | |||
| 2022-01-20 | 2022-01-20 | 4 | Collier William H. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 787.550 | 2.213 | 787.550 | |||
| 2021-12-03 | 2021-12-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 5,0900 | -200.000 | -1.018 | 1.303.403 | ||||
| 2021-11-12 | 2021-11-09 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 3,50 | 44.000 | 44.000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Series A participating convertible preferred shares | D | 7,13 | -1.164.000 | 0 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Common shares, without par value | D | 22.833.922 | 38.847.462 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Meyers James R | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Torti Frank | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Picchio Gaston | ABUS | Stock Options | D | 4,33 | 250.000 | 250.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 4,33 | 250.000 | 250.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Collier William H. | ABUS | Stock Options | D | 4,33 | 675.000 | 675.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 4,33 | 200.000 | 200.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 4,33 | 249.000 | 249.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 4,33 | 290.000 | 290.000 | |||||
| 2021-02-10 | 2021-02-09 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | -20.000 | -100 | 1.307.457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0032 | -10.000 | -50 | 1.327.457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | -30.000 | -150 | 1.337.457 | ||||
| 2020-09-25 | 2020-09-23 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 70.000 | 70.000 | |||||
| 2020-09-25 | 2020-09-23 | 4 | Picchio Gaston | ABUS | Common Stock | D | 3,35 | 50.000 | 50.000 | |||||
| 2020-07-27 | 2020-07-23 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0100 | -20.000 | -100 | 1.367.457 | ||||
| 2020-06-01 | 2020-05-28 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 262.313 | 262.313 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Meyers James R | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Torti Frank | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 3,35 | 200.000 | 200.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 3,35 | 100.000 | 100.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 367.087 | 367.087 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Picchio Gaston | ABUS | Stock Options | D | 3,35 | 150.000 | 150.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 3,35 | 250.000 | 250.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 3,35 | 79.500 | 79.500 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Torti Frank | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Meyers James R | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | POTTER MYRTLE S | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Cheng Andrew | ABUS | Stock Options | D | 1,50 | 60.000 | 60.000 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Collier William H. | ABUS | Employee Stock Option (Right to Buy) | D | 2,18 | 1.112.000 | 1.112.000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137.500 | 137.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137.500 | 137.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 357.500 | 357.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | McElhaugh Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 104.500 | 104.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 145.000 | 145.000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Picchio Gaston | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137.500 | 137.500 | |||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.774.914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.774.914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.774.914 | ||||||||
| 2018-12-13 | 2018-12-11 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 4,44 | 7.500 | 7.500 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 1,35 | -25.000 | 0 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Common Shares | D | 1,3500 | 25.000 | 34 | 341.396 | ||||
| 2018-11-27 | 2018-11-26 | 4 | Torti Frank | ABUS | Director Share Option (right to buy) | D | 4,72 | 44.000 | 44.000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | POTTER MYRTLE S | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44.000 | 44.000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | Meyers James R | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44.000 | 44.000 | |||||
| 2018-10-10 | 2018-10-08 | 4 | Picchio Gaston | ABUS | Employee Share Option (Right to Buy) | D | 9,38 | 200.000 | 200.000 | |||||
| 2018-08-15 | 2018-08-13 | 4/A | Sofia Michael J. Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 | ABUS | Common Shares | I | 9,5143 | -4.250 | -40 | 167.162 | ||||
| 2018-08-14 | 2018-08-13 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 9,5143 | -4.250 | -40 | 1.499.153 | ||||
| 2018-07-13 | 2018-07-11 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 10,0000 | -10.000 | -100 | 1.503.403 | ||||
| 2018-07-10 | 2018-07-09 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,9060 | -10.000 | -89 | 1.513.403 | ||||
| 2018-07-10 | 2018-07-06 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4500 | -10.000 | -84 | 1.523.403 | ||||
| 2018-07-06 | 2018-07-05 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4000 | -10.000 | -84 | 1.533.403 | ||||
| 2018-07-06 | 2018-07-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | -10.000 | -80 | 1.543.403 | ||||
| 2018-06-25 | 2018-06-19 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | MANCHESTER KEITH S | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | Ramaswamy Vivek | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-21 | 2018-06-19 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 6,75 | 200.000 | 200.000 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 160.000 | 160.000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 25.000 | 25.000 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | -27.007 | 0 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Common Shares | D | 0,3540 | 27.007 | 10 | 316.396 | ||||
| 2018-04-17 | 2018-04-16 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 418.187 | 418.187 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 150.000 | 150.000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 30.000 | 30.000 | |||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5.500 | ||||||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5.500 | ||||||||
| 2018-01-16 | 2018-01-12 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Lo Andrew | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Machado Patrick See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2017-10-18 | 2017-10-16 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Lo Andrew See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Machado Patrick | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-05 | 2017-10-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | -10.000 | -80 | 1.553.403 | ||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,6750 | -20.000 | -74 | 171.412 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,7500 | -10.000 | -38 | 191.412 | ||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-06-23 | 2017-06-21 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | Ramaswamy Vivek | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125.000 | 125.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 450.000 | 450.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 150.000 | 150.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 50.000 | 50.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 200.000 | 200.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125.000 | 125.000 | |||||
| 2017-03-27 | 2017-03-24 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 3,15 | 50.000 | 50.000 | |||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 13.503 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 675 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Common Shares | D | 0,3455 | 14.178 | 5 | 42.097 | ||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Warrants | D | 2,57 | -5.000 | 0 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Common Shares | D | 2,5688 | 5.000 | 13 | 289.389 | ||||
| 2016-06-07 | 2016-06-03 | 4 | KARBE FRANK | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 50.000 | 50.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 145.000 | 145.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Kowalski Mark | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 85.000 | 85.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 60.000 | 60.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 450.000 | 450.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Symonds William T. | ABUS | Executive Stock Option (Right to Buy) | D | 3,94 | 25.000 | 25.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 100.000 | 100.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 120.000 | 120.000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35.000 | 35.000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75.000 | 75.000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100.000 | 100.000 | |||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77.516 | ||||||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77.516 | ||||||||
| 2015-12-22 | 2015-07-09 | 4 | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100.000 | 100.000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75.000 | 75.000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35.000 | 35.000 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | -219.428 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Common Shares | D | 0,4444 | 219.428 | 98 | 284.389 | ||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | -17.044 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Common Shares | D | 0,4444 | 17.044 | 8 | 27.919 | ||||
| 2015-08-26 | 2015-08-24 | 4 | HENRIQUES RICHARD C JR | ABUS | Common Shares | D | 6,9500 | 1.000 | 7 | 1.000 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | CONRAD HERBERT J | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-04-08 | 2015-03-30 | 4 | HENRIQUES RICHARD C JR | TKMR | Stock Option (right to buy) | D | 17,57 | 15.000 | 15.000 | |||||
| 2015-04-07 | 2015-03-30 | 4 | CONRAD HERBERT J | TKMR | Stock Option (right to buy) | D | 17,57 | 15.000 | 15.000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Abrams Michael J. | TKMR | Stock Option (right to buy) | D | 17,57 | 50.000 | 50.000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Cousins Bruce | TKMR | Stock Option (right to buy) | D | 17,57 | 80.000 | 80.000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Murray Mark J. | TKMR | Stock Option (right to buy) | D | 17,57 | 180.000 | 180.000 | |||||
| 2015-03-16 | 3 | CONRAD HERBERT J | TKMR | Common Stock | D | 0 | ||||||||
| 2015-03-16 | 3 | MANCHESTER KEITH S | TKMR | Common Stock, no par value | I | 0 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1.966.227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3.328.218 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1.966.227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3.328.218 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512.654 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512.654 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3.529.630 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3.529.630 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16.123.370 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32.081.995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32.081.995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16.123.370 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32.027.080 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38.000 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38.000 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21.750 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21.750 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129.922 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129.922 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969.330 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969.330 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77.516 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77.516 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20.000 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20.000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10.000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10.000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25.000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25.000 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
